CytoDyn Inc. (CYDY)
OTCMKTS · Delayed Price · Currency is USD
0.1950
-0.0050 (-2.50%)
Sep 8, 2026, 1:27 PM EST
CytoDyn Income Statement
Financials in millions USD. Fiscal year is June - May.
Millions USD. Fiscal year is Jun - May.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
| - | - | - | - | 0.27 | |
Revenue Growth | - | - | - | - | - |
Cost of Revenue | - | - | - | 20.63 | 73.54 |
Gross Profit | - | - | - | -20.63 | -73.28 |
Selling, General & Admin | 7.45 | 7.26 | 10.82 | 17.14 | 44.3 |
Research & Development | 15.7 | -16.92 | 7.24 | 2.63 | 27.04 |
Amortization of Goodwill & Intangibles | - | - | - | 0.13 | - |
Operating Expenses | 23.15 | -9.66 | 18.06 | 19.94 | 72.13 |
Operating Income | -23.15 | 9.66 | -18.06 | -40.58 | -145.4 |
Interest Expense | -2.51 | -4.86 | -8.89 | -15.51 | -24.18 |
Interest & Investment Income | 0.26 | 0.57 | 0.22 | - | - |
Other Non Operating Income (Expenses) | -1.95 | -0.85 | -3.06 | -18.43 | - |
EBT Excluding Unusual Items | -27.35 | 4.52 | -29.79 | -74.51 | -169.59 |
Legal Settlements | -15.35 | - | - | - | -3.85 |
Other Unusual Items | - | -0.77 | -20.05 | -5.31 | -37.38 |
Pretax Income | -42.7 | 3.75 | -49.84 | -79.82 | -210.82 |
Net Income | -42.7 | 3.75 | -49.84 | -79.82 | -210.82 |
Preferred Dividends & Other Adjustments | 1.48 | 1.48 | 1.48 | 6.91 | 1.63 |
Net Income to Common | -44.18 | 2.26 | -51.32 | -86.74 | -212.45 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 1,289 | 1,206 | 970 | 837 | 677 |
Shares Outstanding (Diluted) | 1,289 | 1,243 | 970 | 837 | 677 |
Shares Change | 3.73% | 28.20% | 15.90% | 23.58% | 15.20% |
EPS (Basic) | -0.03 | 0.00 | -0.05 | -0.10 | -0.31 |
EPS (Diluted) | -0.03 | 0.00 | -0.05 | -0.10 | -0.31 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 |
Free Cash Flow | -17.25 | -8.77 | -10.98 | -25.11 | -77.72 |
Free Cash Flow Per Share | -0.01 | -0.01 | -0.01 | -0.03 | -0.12 |
Operating Margin | - | - | - | - | -54663.16% |
Profit Margin | - | - | - | - | -79867.67% |
Free Cash Flow Margin | - | - | - | - | -29219.17% |
EBITDA | -23.13 | 9.68 | -18.03 | -40.4 | -144.62 |
D&A For EBITDA | 0.02 | 0.02 | 0.03 | 0.18 | 0.78 |
EBIT | -23.15 | 9.66 | -18.06 | -40.58 | -145.4 |